Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mario G. Pessôa"'
Autor:
Mario G. Pessôa, Hugo Cheinquer, Paulo R.L. Almeida, Giovanni F. Silva, Maria Patelli J.S. Lima, Raymundo Paraná, Marco A. Lacerda, Edison R. Parise, José R.B. Pernambuco, Suelene S. Pedrosa, Rosângela Teixeira, Hoel Sette, Jr, Fernando Tatsch
Publikováno v:
Annals of Hepatology, Vol 11, Iss 1, Pp 52-61 (2012)
Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patien
Externí odkaz:
https://doaj.org/article/cb9c25b8cf664fe586ab76e36c2da4f2
Autor:
Nahum Méndez-Sánchez, Raymundo Paraná, Hugo Cheinquer, Angelo Alves de Mattos, Adrian Gadano, Marcelo Silva, Mario G. Pessôa, Maria L. Gomes-Ferraz, Alejandro Soza, M. Cassia Mendes-Correa, Norberto C. Chávez-Tapia, Lucy Dagher, Martín Padilla, Nelia Hernandez, Juan F. Sánchez-Avila, Fernando Contreras, Henrique S. Moraes-Coelho, Edison R. Parise, Fernando Bessone, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 13, Iss , Pp S4-S66 (2014)
Externí odkaz:
https://doaj.org/article/27d63c21021040f5a598cb1584f151ff
Autor:
Roseane P. Medeiros, Norah A. Terrault, Daniel F. Mazo, Claudia P. Oliveira, Jennifer Dodge, Patricia M. Zitelli, Marta H. Lopes, Flair J. Carrilho, Mário G. Pessoa
Publikováno v:
Annals of Hepatology, Vol 28, Iss 2, Pp 100891- (2023)
Introduction and Objectives: Some studies suggest chronic HCV infection diminishes responses to the anti-HBV vaccine. We evaluated the efficacy of double versus standard dose HBV vaccination among HCV patients without cirrhosis. Patients and Methods:
Externí odkaz:
https://doaj.org/article/80f3449233ee458d896c0bc3c5ea0f81
Autor:
Mario G, Pessôa, Hugo, Cheinquer, Paulo R L, Almeida, Giovanni F, Silva, Maria Patelli J S, Lima, Raymundo, Paraná, Marco A, Lacerda, Edison R, Parise, José R B, Pernambuco, Suelene S, Pedrosa, Rosângela, Teixeira, Hoel, Sette, Fernando, Tatsch
Publikováno v:
Annals of hepatology. 11(1)
A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care(pegylated interferon plus ribavirin) in patients who had not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fb2d777d9ab3e79653a3572be8e2291
https://pubmed.ncbi.nlm.nih.gov/22166561
https://pubmed.ncbi.nlm.nih.gov/22166561
Autor:
Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Despite the growing body of knowledge about TM6SF2 and PNPLA3 polymorphisms in non-alcoholic fatty liver disease, their influence in the spectrum of HCV liver disease is not yet fully defined. Besides that, admixed populations, su
Externí odkaz:
https://doaj.org/article/094ead3f78644ec69b06e29857797951
Autor:
Adauto, Castelo, Mario G, Pessôa, Tânia C B B, Barreto, Marcia R D, Alves, Denizar Vianna, Araújo
Publikováno v:
Revista da Associacao Medica Brasileira (1992). 53(6)
Chronic Hepatitis B Virus (CHBV) is a disease that places a large financial burden on healthcare systems and society.The aim of this study was to estimate patient management patterns, and associated medical resource utilization and expenses, for each
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9fde598344768d02d26b7b574a59ec6b
https://pubmed.ncbi.nlm.nih.gov/18157360
https://pubmed.ncbi.nlm.nih.gov/18157360
Autor:
Mariana Sandoval Lourenço, Patricia Momoyo Y. Zitelli, Marlone Cunha-Silva, Arthur Ivan N. Oliveira, Roque Gabriel Rezende de Lima, Evandro de Oliveira Souza, Claudia P. Oliveira, Tiago Sevá-Pereira, Flair J. Carrilho, Mario G. Pessoa, Daniel F. Mazo
Publikováno v:
Clinics, Vol 76 (2021)
OBJECTIVES: Despite higher rates of sustained virologic response (SVR), important concerns remain when patients with decompensated cirrhosis due to hepatitis C virus (HCV) are treated with direct-acting antiviral agents (DAA). Questions include effic
Externí odkaz:
https://doaj.org/article/c0144cf63bde4bbba543988bc4640bc1
Autor:
Guilherme G.L. Cançado, Eduardo L.R. Cançado, Maria L.G. Ferraz, Cristiane A. Villela-Nogueira, Debora R.B. Terrabuio, Michelle H. Braga, Mateus J. Nardelli, Luciana C. Faria, Nathalia M.F. GOMES, Elze M.G. Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone M.C.F. Cunha, Daniel F.C. Mazo, Liliana S.C. Mendes, Claudia A.P. Ivantes, Valéria F.A. Borges, Fabio H.L. Pace, Mario G. Pessoa, Izabelle V. Signorelli, Gabriela P. Coral, Paulo L. Bittencourt, Cynthia Levy, Cláudia A. Couto
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100393- (2021)
Introduction: Little is known about primary biliary cholangitis (PBC) in Latin America, where this disease is thought to be rare. Objectives: To analyze clinical and biochemical features of Brazilian PBC patients. Methods: The Brazilian Cholestasis S
Externí odkaz:
https://doaj.org/article/aee863cc7c0d4510bbe7917b03855119
Autor:
Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100488- (2021)
Background: Despite the growing body of knowledge about TM6SF2 and PNPLA3 polymorphisms in non-alcoholic fatty liver disease, their influence in the spectrum of HCV liver disease is not yet fully defined. Besides that, admixed populations, such as Br
Externí odkaz:
https://doaj.org/article/b66c7a3b44e7467f98db1b59555b4b37
Autor:
Guilherme G.L. Cançado, Eduardo L.R. Cançado, Maria L.G. Ferraz, Cristiane A. Villela-Nogueira, Debora R.B. Terrabuio, Michelle H. Braga, Mateus J. Nardelli, Luciana C. Faria, Nathalia M.F. GOMES, ELZE M.G. Oliveira, Vivian Rotman, Maria Beatriz Oliveira, Simone M.C.F. Cunha, Daniel F. Mazo, Liliana S.C. Mendes, Claudia A.P. Ivantes, Valéria Faborges, Fabio H.L. Pace, Mario G. Pessoa, Izabelle V. Signorelli, Gabriela P. Coral, Paulo L. Bittencourt, Cynthia Levy, Cláudia A. Couto, Members of the Brazilian Cholestasis Study Group Consortium
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100497- (2021)
Introduction: Primary biliary cholangitis (PBC) diagnosis is based on international criteria, which requires two of the following: (i) elevated alkaline phosphatase (AP), (ii) anti-mitochondrial antibody (AMA) and (iii) liver biopsy (BX) suggestive o
Externí odkaz:
https://doaj.org/article/134f233189814aa3a1344acc6d8e8a72